Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheldon W Tobe

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
Kidney International|April 24, 2019
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAlfred K Cheung, Tara I Chang, William C Cushman, et al.
The Canadian Journal of Cardiology|June 7, 2006
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of riskB R Hemmelgarn, Finlay A McAlister, Steven Grover, et al.
Diabetes, Obesity & Metabolism|December 27, 2016
The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathyMichelle J Pena, Dick de Zeeuw, Dennis Andress, et al.
Current Hypertension Reports|March 21, 2015
MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): a review & study protocolKimberly C Blom, Sasha Farina, Yessica-Haydee Gomez, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 14, 2011
Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE InitiativeSheldon W Tobe, James A Stone, Melissa Brouwers, et al.
The Canadian Journal of Cardiology|March 4, 2019
Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern OntarioPatrick J Donio, Cassandra Freitas, Peter C Austin, et al.
Drugs in R&D|August 24, 2017
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialDavid J Webb, Blai Coll, Hiddo J L Heerspink, et al.
Global Heart|July 21, 2019
Systematic Review of Hypertension and Diabetes Burden, Risk Factors, and Interventions for Prevention and Control in Malawi: The NCD BRITE ConsortiumAlemayehu Amberbir, Sabrina H Lin, Joshua Berman, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 22, 2014
Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 updateSheldon W Tobe, James A Stone, Kimberly M Walker, et al.
Kidney International|February 27, 2021
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseAlfred K Cheung, Tara I Chang, William C Cushman, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Kidney International|April 24, 2019
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceAlfred K Cheung, Tara I Chang, William C Cushman, et al.
The Canadian Journal of Cardiology|June 7, 2006
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of riskB R Hemmelgarn, Finlay A McAlister, Steven Grover, et al.
Diabetes, Obesity & Metabolism|December 27, 2016
The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathyMichelle J Pena, Dick de Zeeuw, Dennis Andress, et al.
Current Hypertension Reports|March 21, 2015
MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): a review & study protocolKimberly C Blom, Sasha Farina, Yessica-Haydee Gomez, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 14, 2011
Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE InitiativeSheldon W Tobe, James A Stone, Melissa Brouwers, et al.
The Canadian Journal of Cardiology|March 4, 2019
Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern OntarioPatrick J Donio, Cassandra Freitas, Peter C Austin, et al.
Drugs in R&D|August 24, 2017
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialDavid J Webb, Blai Coll, Hiddo J L Heerspink, et al.
Global Heart|July 21, 2019
Systematic Review of Hypertension and Diabetes Burden, Risk Factors, and Interventions for Prevention and Control in Malawi: The NCD BRITE ConsortiumAlemayehu Amberbir, Sabrina H Lin, Joshua Berman, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 22, 2014
Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 updateSheldon W Tobe, James A Stone, Kimberly M Walker, et al.
Kidney International|February 27, 2021
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseAlfred K Cheung, Tara I Chang, William C Cushman, et al.
Pageof 16